Chemotherapy-related complication burden in patients with metastatic breast cancer in a real-world setting

被引：1
|
作者：
Hurvitz, S. A.
Lalla, D.
Guerin, A.
Latremouille-Viau, D.
Yu, A. P.
Wu, E. Q.
Brammer, M.
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Anal Grp Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11101
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Costs associated with chemotherapy-related complications in the treatment of metastatic breast cancer in a real-world setting
    Guerin, A.
    Lalla, D.
    Latremouille-Viau, D.
    Yu, A. P.
    Wu, E. Q.
    Brammer, M.
    Hurvitz, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Investigation of Adverse-Event-Related Costs for Patients With Metastatic Breast Cancer in a Real-World Setting
    Hurvitz, Sara
    Guerin, Annie
    Brammer, Melissa
    Guardino, Ellie
    Zhou, Zheng-Yi
    Viau, Dominick Latremouille
    Wu, Eric Q.
    Lalla, Deepa
    ONCOLOGIST, 2014, 19 (09): : 901 - 908
  • [3] Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system
    Rashid, Nazia
    Koh, Han A.
    Baca, Hilda C.
    Lin, Kathy J.
    Malecha, Susan E.
    Masaquel, Anthony
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 173 - 181
  • [4] Ixabepilone efficacy and tolerability in metastatic breast cancer (MBC) patients in a real-world setting.
    Hyder, Tara
    Rosenzweig, Margaret Q.
    Brufsky, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
    Olsson, Erik
    Lindman, Henrik
    Digkas, Evangelos
    Thurfjell, Viktoria
    Ali, Haidar Mir
    Kruger, Ute
    Wennstig, Anna-Karin
    Sundqvist, Marie
    Valachis, Antonios
    BREAST, 2025, 79
  • [6] Risk of trastuzumab-related cardiotoxicity in early breast cancer patients in real-world setting
    Xue Jian
    Zhang Xiaozhong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C102 - C102
  • [7] Neutropenic complications in Chinese patients with breast cancer in a real-world setting
    Ye, Xuan
    Zhai, Qing
    Wang, Zhe-Yuan
    Du, Qiong
    Zhu, Bin
    Yu, Bo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 651 - 660
  • [8] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [9] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [10] A real-world retrospective study of apatinib plus chemotherapy in metastatic breast cancer.
    Zhu, Anjie
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Li, Qing
    Zhang, Pin
    Xu, Binghe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345